MPP+

MPP+ (1-methyl-4-phenylpyridinium) is a neurotoxin with a significant role in scientific research, particularly in studies related to Parkinson's disease. It is a byproduct of the synthetic opioid MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), and is known to cause permanent symptoms of Parkinson's disease by destroying dopaminergic neurons in the substantia nigra region of the brain.

Structure and Properties

MPP+ is a positively charged molecule, which allows it to cross the blood-brain barrier via the organic cation transporter (OCT3). Its structure includes a pyridinium ring, which is essential for its neurotoxicity.

Mechanism of Action

Once inside the brain, MPP+ is taken up by dopaminergic neurons through the dopamine transporter. It then accumulates in the mitochondria, where it interferes with the function of complex I of the electron transport chain. This disruption leads to a decrease in ATP production and an increase in oxidative stress, ultimately resulting in cell death.

Role in Parkinson's Disease Research

MPP+ has been instrumental in the study of Parkinson's disease. It has been used to create animal models of the disease, which have provided valuable insights into its pathogenesis and potential treatments. However, it is important to note that while MPP+ induces Parkinson-like symptoms, it does not fully replicate the disease's progression or all of its symptoms.

Safety

Due to its neurotoxicity, MPP+ must be handled with care. It is typically stored as a stable iodide salt, which is less hazardous than the free cation.

See Also

• MPTP
• Parkinson's disease
• Neurotoxin
• Substantia nigra
• Dopamine transporter

MPP+ Resources
Latest articles Most recent articles Ongoing trials	Wikipedia